Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Angermayer, Aperion, BioPharma, Cambrian, canceled, cancelled, Christian, cohort, deadline, exceeded, excise, Peyer, physical, Presight, repurchase, retired, settlement, SICAV, standstill, thirty, unconditional, withhold
Removed:
identified, infection, recurrence, serum, spread
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view